In a preclinical study led by McGill University researchers, two drugs targeting “zombie cells” have been shown to treat the underlying cause of chronic low back pain. The condition affects millions of people worldwide.
Current treatments manage…
Category: 5. Health
-
Reclaiming America’s Biotech Edge Before It’s Too Late
Illustration of scientists in a pharma lab, representing investment in research and development.
“Economic security and national security are almost directly related in the long run,” said J.P. Morgan CEO Jamie Dimon last week on Fox…
Continue Reading
-
We’re Releasing Millions Of Birds. The Ticks Are Thriving.
BURSA, TURKIYE – OCTOBER 07: A pheasant is seen among grasses in Bursa, Turkiye on October 07, 2024. … More
Continue Reading
-
Elevance Health Overcomes Rising Costs, Reports $2 Billion Profit
Despite rising costs in its health plans, Elevance Health reported more than $2 billion in first … More
Continue Reading
-
More Americans are using psilocybin — especially those with mental health conditions, study shows
Use of psilocybin, the hallucinogenic chemical found in what is known as “magic mushrooms,” has increased significantly nationwide since 2019, according to a new study led by researchers at the University of Colorado Anschutz Medical Campus and…
Continue Reading
-
Novel treatment approach for language disorder shows promise
Primary progressive aphasia is a neurological condition that causes a gradual decline in language abilities. There is no cure or medication that can reverse or stop the progression of PPA. The standard practice in the clinical setting is…
Continue Reading
-
High-fat, high-sugar diets impact cognitive function
New research from the University of Sydney links fatty, sugary diets to impaired brain function. The findings build on a growing body of evidence showing the negative impact of high-fat, high-sugar (HFHS) diets on cognitive ability, adding to…
Continue Reading
-
Older adults respond well to immunotherapy despite age-related immune system differences
Older adults with cancer respond just as well as younger patients to immune checkpoint inhibitors despite age-related immune system differences, according to a study by researchers from the Johns Hopkins Kimmel Cancer Center and its…
Continue Reading
-
Omnivorous? Vegan? Makes no difference to muscle building after weight training, study finds
A new study asked three questions about muscle protein synthesis in response to a nine-day diet and weight training regimen: First, does the source of protein — plant or animal-based — make any difference to muscle gain? Second, does it matter…
Continue Reading
-
Experimental cancer drug could streamline standard tuberculosis treatment and prevent post-TB lung disease, study suggests
An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, Johns Hopkins Medicine investigators report, based on…
Continue Reading